Scientists Created a Tool for Targeted Drug Delivery to Tumor
One of the methods of cancer treatment is chemotherapy. Cytostatic drugs are usually administered intravenously, they help to minimize the growth of the tumor, but at the same time they put a serious strain on the body and cause side effects. Targeted drug delivery systems help improve the effectiveness of treatment and reduce side effects. However, there is no exact targeted delivery method yet. RUDN University chemists, together with colleagues from Iran, have proposed a hydrogel compound made of graphene and gelatin that can potentially deliver the anti-cancer drug doxorubicin to a tumor.
“It is important to introduce an alternative vehicle that can deliver anticancer drugs effectively in the targeted tumor tissue. Based on our previous findings in modification/functionalization of materials via multicomponent reactions we report a green, straightforward, and efficient novel method to prepare GQD-G hydrogel, which can be used as an implantable antitumor agent,” said Ahmad Shaabani, a leading researcher at the Joint Institute for Chemical Research of RUDN and SBU.
Chemists have created a hydrogel that can hold a drug and slowly release it as it dissolves. The GQD-G hydrogel consists of gelatin and graphene-based quantum dots. Quantum dots are semiconductor particles with electrons “trapped” in it. They were obtained by pyrolysis of citric acid. The solution with quantum dots was combined with gelatin and excipients (bromobenzaldehyde and cyclohexyl isocyanide) to form a hydrogel, a “vehicle” for the drug. Then they injected doxorubicin in it (a common drug used in cancer chemotherapy). Cytotoxicity of the drug was studied on breast cancer cells.
Within 100 hours, up to 25-70% of doxorubicin is released from the hydrogel compound, depending on the acidity of the environment and the concentration of auxiliary bromobenzaldehyde in the hydrogel. The ability to kill cancer cells in this compound was lower than that of pure doxorubicin, but the hydrogel complex provides another advantage. One can control the rate of drug release and reduce side effects, since the hydrogel with the drug can be injected directly into the desired tissue.
“The designed hydrogels may attract great attention to construct a safe system, having the potential to be employed as an implantable anticancer and bio-detection agent. In addition, we believe that the presented strategy could attract much attention from the community of material chemistry for the preparation of biomedical platforms thanks to its green chemistry principle,” said Ahmad Shaabani, a leading researcher at the Joint Institute for Chemical Research of RUDN and SBU.
The results are published in the journal Materialia. https://www.sciencedirect.com/science/article/abs/pii/S2589152921002362
Imagine a world where everyone has enough food, clean water, access to education, and decent work. A world where nature is protected and the future of our planet is cared for. These are the Sustainable Development Goals—to achieve a sustainable future for all! To this end, in 2015, the United Nations (UN) defined 17 Sustainable Development Goals (SDGs). The SDGs are a global plan that helps countries and people work together towards a better future. All 193 UN member states have joined the plan.
Researchers from the Faculty of Artificial Intelligence at RUDN University conducted a large-scale study that revealed systemic errors in large language models (LLMs) when diagnosing depression based on text. This work, carried out in collaboration with colleagues from AIRI, Federal Research Center “Computer Science and Control” of the Russian Academy of Sciences, Ivannikov Institute for System Programming of the Russian Academy of Sciences, Moscow Institute of Physics and Technology, and MBZUAI, not only identifies the problem but also lays the foundation for the creation of more reliable and secure tools for detecting depression and anxiety.
Alexandra Sentyabreva, a junior researcher at the Laboratory of Cell Technologies and Tissue Engineering at RUDN Research Institute of Molecular and Cellular Medicine at the Russian University of People's Friendship, won the competition for young scientists at the All-Russian Scientific Conference “Topical Issues of Morphogenesis in Norm and Pathology.” She was awarded the Academician A.P. Avtsyn Prize.
Imagine a world where everyone has enough food, clean water, access to education, and decent work. A world where nature is protected and the future of our planet is cared for. These are the Sustainable Development Goals—to achieve a sustainable future for all! To this end, in 2015, the United Nations (UN) defined 17 Sustainable Development Goals (SDGs). The SDGs are a global plan that helps countries and people work together towards a better future. All 193 UN member states have joined the plan.
Researchers from the Faculty of Artificial Intelligence at RUDN University conducted a large-scale study that revealed systemic errors in large language models (LLMs) when diagnosing depression based on text. This work, carried out in collaboration with colleagues from AIRI, Federal Research Center “Computer Science and Control” of the Russian Academy of Sciences, Ivannikov Institute for System Programming of the Russian Academy of Sciences, Moscow Institute of Physics and Technology, and MBZUAI, not only identifies the problem but also lays the foundation for the creation of more reliable and secure tools for detecting depression and anxiety.
Alexandra Sentyabreva, a junior researcher at the Laboratory of Cell Technologies and Tissue Engineering at RUDN Research Institute of Molecular and Cellular Medicine at the Russian University of People's Friendship, won the competition for young scientists at the All-Russian Scientific Conference “Topical Issues of Morphogenesis in Norm and Pathology.” She was awarded the Academician A.P. Avtsyn Prize.